Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21270442 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Intervention: Drug: lestaurtinib

Indicates status has not been verified in more than two years